{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:41:27Z","timestamp":1791895287366,"version":"4.3.4"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Neurol"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1007\/s11940-014-0288-3","type":"journal-article","created":{"date-parts":[[2014,3,31]],"date-time":"2014-03-31T01:39:38Z","timestamp":1396229978000},"source":"Crossref","is-referenced-by-count":23,"title":["Anti-Epileptic Drugs and Hormonal Treatments"],"prefix":"10.1007","volume":"16","author":[{"given":"Clare A.","family":"Johnston","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela M.","family":"Crawford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,4,1]]},"reference":[{"issue":"9","key":"288_CR1","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1093\/humrep\/dem184","volume":"22","author":"C Moreau","year":"2007","unstructured":"Moreau C, Trussell J, Rodriguez G, et al. Contraceptive failure rates in France: results from a population-based survey. J Hum Reprod. 2007;22(9):2422\u20137.","journal-title":"J Hum Reprod"},{"issue":"1","key":"288_CR2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1528-1167.2012.03671.x","volume":"54","author":"MJ Brodie","year":"2013","unstructured":"Brodie MJ, Mintzer S, Pack AM, et al. Enzyme induction with antiepileptic drugs: cause for concern? Epilepsia. 2013;54(1):11\u201327. An interesting review considering the potential clinical implications of the hepatic enzyme inducing effects of anti-epileptic drugs.","journal-title":"Epilepsia"},{"key":"288_CR3","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S1474-4422(11)70047-3","volume":"10","author":"E Perucca","year":"2011","unstructured":"Perucca E, Tomson T. The pharmacological treatment of epilepsy in adults. Lancet Neurol. 2011;10:446\u201356.","journal-title":"Lancet Neurol"},{"key":"288_CR4","doi-asserted-by":"crossref","first-page":"e345","DOI":"10.1136\/bmj.e345","volume":"344","author":"MJ Brodie","year":"2012","unstructured":"Brodie MJ, Kwan P. Newer drugs for focal epilepsy in adults. BMJ. 2012;344:e345. Review of the newer drugs used for the treatment of epilepsy.","journal-title":"BMJ"},{"key":"288_CR5","unstructured":"Faculty of Sexual and Reproductive Healthcare Clinical Effectiveness Statement. Update on newer antiepileptic and antiretroviral drugs and interactions with hormonal contraceptives. 2013. Available at: http:\/\/www.fsrh.org\/pdfs\/CEUstatementUpdateNewerAntiepilepticAntiretroviralDrugs.pdf Accessed December 21, 2013. Updated hormonal contraceptive guidelines detailing potential interactions with newer anti-epileptic drugs."},{"key":"288_CR6","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1528-1167.2007.00997.x","volume":"48","author":"J Christensen","year":"2007","unstructured":"Christensen J, Petrenaite V, Atterman J, et al. Oral contraceptives induce lamotrigine metabolism: evidence from a double-blind, placebo-controlled trial. Epilepsia. 2007;48:484\u20139.","journal-title":"Epilepsia"},{"key":"288_CR7","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1212\/01.WNL.0000076485.09353.7A","volume":"61","author":"A Sabers","year":"2003","unstructured":"Sabers A, \u00d6hman I, Christensen J, et al. Oral contraceptives reduce lamotrigine plasma levels. Neurology. 2003;61:570\u20131.","journal-title":"Neurology"},{"issue":"9","key":"288_CR8","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1528-1167.2005.10105.x","volume":"46","author":"A Reimers","year":"2005","unstructured":"Reimers A, Helde G, Brodtkorb E. Ethinyl estradiol, not progestogens, reduces lamotrigine serum concentrations. Epilepsia. 2005;46(9):342\u20138.","journal-title":"Epilepsia"},{"key":"288_CR9","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1365-2125.2005.02539.x","volume":"61","author":"J Sidhu","year":"2006","unstructured":"Sidhu J, Job S, Singh S, Philipson R. The pharmacokinetic and pharmacodynamic consequences of the co-administration of lamotrigine and a combined oral contraceptive in healthy female subjects. Br J Clin Pharmacol. 2006;61:191\u20139.","journal-title":"Br J Clin Pharmacol"},{"key":"288_CR10","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1111\/j.1528-1167.2006.00629.x","volume":"47","author":"CA Galimberti","year":"2006","unstructured":"Galimberti CA, Mazzucchelli I, Arbazino C, et al. Increased apparent oral clearance of valproate acid during intake of combined contraceptive steroids in women with epilepsy. Epilepsia. 2006;47:1569\u201372.","journal-title":"Epilepsia"},{"key":"288_CR11","first-page":"533","volume":"11","author":"E Perucca","year":"1984","unstructured":"Perucca E, Hedges A, Makki KA, et al. A comparative study of the relative enzyme inducing properties of anticonvulsant drugs in antiepileptic patients. Br J Pharmacol. 1984;11:533\u20139.","journal-title":"Br J Pharmacol"},{"key":"288_CR12","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/00007691-198909000-00008","volume":"11","author":"T Tomson","year":"1989","unstructured":"Tomson T, Svensson J, Hilton-Brown P. Relationship of inter-individual dose to plasma concentration of carbamazepine: indication of dose-dependent induction of metabolism. Ther Drug Monit. 1989;11:533\u20139.","journal-title":"Ther Drug Monit"},{"key":"288_CR13","doi-asserted-by":"crossref","first-page":"210","DOI":"10.2165\/00003088-199732030-00004","volume":"32","author":"RJ Bertz","year":"1997","unstructured":"Bertz RJ, Granneman GR. Use of in vitro and in vivo data to estimate likelihood of metabolic pharmacodynamic interactions. Clin Pharmacokinet. 1997;32:210\u201358.","journal-title":"Clin Pharmacokinet"},{"key":"288_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10408449209145319","volume":"22","author":"SA Wright","year":"1992","unstructured":"Wright SA, Stevens JC. The human hepatic cytochromes 450 involved in drug metabolism. Crit Rev Toxicol. 1992;22:1\u201321.","journal-title":"Crit Rev Toxicol"},{"issue":"Suppl 5","key":"288_CR15","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1111\/j.1528-1157.1995.tb06007.x","volume":"36","author":"RH Levy","year":"1995","unstructured":"Levy RH. Cytochrome P450 isoenzymes and antiepileptic drug interactions. Epilepsia. 1995;36 Suppl 5:S8\u2013S13.","journal-title":"Epilepsia"},{"issue":"Suppl 4","key":"288_CR16","first-page":"47","volume":"36","author":"RH Levy","year":"1995","unstructured":"Levy RH, Bishop F, Streeter AJ. Explanation and prediction of drug interactions with topiramate using CYP450 inhibition spectrum. Epilepsia. 1995;36 Suppl 4:47\u201351.","journal-title":"Epilepsia"},{"issue":"2","key":"288_CR17","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1528-1167.2010.02917.x","volume":"52","author":"AR Davis","year":"2011","unstructured":"Davis AR, Westhoff CL, Stanczyk FZ. Carbamazepine coadministration with an oral contraceptive: effects on steroid pharmacokinetics, ovulation and bleeding. Epilepsia. 2011;52(2):243\u20137.","journal-title":"Epilepsia"},{"issue":"Suppl 4","key":"288_CR18","first-page":"90","volume":"37","author":"RA Giuliano","year":"1996","unstructured":"Giuliano RA, Hiersemenzel E, Baltes G. Influence of a new antiepileptic drug (Levetiracetam, ucbLO59) on the pharmacokinetics and pharmacodynamics of oral contraceptives. Epilepsia. 1996;37 Suppl 4:90.","journal-title":"Epilepsia"},{"key":"288_CR19","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1212\/WNL.50.4.1146","volume":"50","author":"MA Eldon","year":"1998","unstructured":"Eldon MA, Underwood BA, Randinitis EJ, et al. Gabapentin does not interact with a contraceptive regimen of norethindrone acetate and ethinyl estradiol. Neurology. 1998;50:1146\u20138.","journal-title":"Neurology"},{"issue":"Suppl 3","key":"288_CR20","first-page":"153","volume":"45","author":"HN Bockbrader","year":"2004","unstructured":"Bockbrader HN, Posvar EL, Hunt T. Pharmacokinetics of pregabalin and a concomitantly administered oral contraceptive shows no drug-drug interaction. Epilepsia. 2004;45 Suppl 3:153.","journal-title":"Epilepsia"},{"key":"288_CR21","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/j.1528-1157.1997.tb01240.x","volume":"38","author":"A Bartoli","year":"1997","unstructured":"Bartoli A, Gatti G, Cipolla G, et al. A double-blind placebo-controlled study on the effect of vigabatrin on in vivo parameters of hepatic microsomal enzyme induction and on the kinetics of steroid oral contraceptives in healthy female volunteers. Epilepsia. 1997;38:702\u20137.","journal-title":"Epilepsia"},{"key":"288_CR22","first-page":"141","volume":"4","author":"HB Mengel","year":"1994","unstructured":"Mengel HB, Houston A, Back DJ. An evaluation of the interaction between tiagabine and oral contraceptives in female volunteers. J Pharm Med. 1994;4:141\u201350.","journal-title":"J Pharm Med"},{"key":"288_CR23","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1016\/j.clinthera.2004.11.019","volume":"12","author":"SG Griffith","year":"2004","unstructured":"Griffith SG, Dai Y. Effect of zonisamide on the pharmacokinetics and pharmacodynamics of a combination ethinyl estradiol-norethindrone oral contraceptive in healthy women. Clin Ther. 2004;12:2056\u201365.","journal-title":"Clin Ther"},{"key":"288_CR24","doi-asserted-by":"crossref","unstructured":"Nakasa H, Nakamura H, Ono S, et al. Prediction of drug-drug interactions of zonisamide in humans from in vitro data. Eur J Clin Pharmacol. 1998; 54(2):177--83.","DOI":"10.1007\/s002280050442"},{"issue":"3","key":"288_CR25","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/epi.12085","volume":"54","author":"W Cawello","year":"2013","unstructured":"Cawello W, Rosenkranz B, Schmid B, et al. Pharmacodynamic and pharmacokinetic evaluation of coadministration of lacosamide and an oral contraceptive (levonorgestrel plus ethinylestradiol) in healthy female volunteers. Epilepsia. 2013;54(3):530\u20136.","journal-title":"Epilepsia"},{"key":"288_CR26","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0010-7824(86)90028-4","volume":"33","author":"P Crawford","year":"1986","unstructured":"Crawford P, Chadwick D, Cleland P, et al. The lack of effect of sodium valproate on the pharmacokinetics of oral contraceptives. Contraception. 1986;33:23\u20139.","journal-title":"Contraception"},{"key":"288_CR27","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1111\/j.1365-2125.1990.tb05457.x","volume":"30","author":"P Crawford","year":"1990","unstructured":"Crawford P, Chadwick D, Martin C, et al. The interaction of phenytoin and carbamazepine with combined oral contraceptive steroids. Br J Clin Pharmacol. 1990;30:892\u20136.","journal-title":"Br J Clin Pharmacol"},{"key":"288_CR28","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2165\/00023210-200216040-00005","volume":"16","author":"P Crawford","year":"2002","unstructured":"Crawford P. Interactions between antiepileptic drugs and hormonal contraception. CNS Drugs. 2002;16:263\u201372.","journal-title":"CNS Drugs"},{"key":"288_CR29","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/0010-7824(80)90102-X","volume":"22","author":"DJ Back","year":"1980","unstructured":"Back DJ, Bates M, Bowden A, et al. The interactions of phenobarbital and other anticonvulsants with oral contraceptive therapy. Contraception. 1980;22:495\u2013503.","journal-title":"Contraception"},{"key":"288_CR30","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1111\/j.1528-1157.1998.tb01316.x","volume":"39","author":"Quality Standards Subcommittee of the American Academy of Neurology","year":"1998","unstructured":"Quality Standards Subcommittee of the American Academy of Neurology. Practice parameter: management issues for women with epilepsy (summary statement). Epilepsia. 1998;39:1226\u201331.","journal-title":"Epilepsia"},{"key":"288_CR31","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1783\/147118905774480644","volume":"31","author":"J Guillebaud","year":"2005","unstructured":"Guillebaud J. Drug interactions with hormonal contraception. J Fam Plan Reprod Health Care. 2005;31:335\u20136.","journal-title":"J Fam Plan Reprod Health Care"},{"key":"288_CR32","first-page":"96","volume-title":"Educational kit on epilepsies, vol 4, epilepsy and women","author":"M Marsh","year":"2008","unstructured":"Marsh M, Kumar U. Practical recommendations for contraception. In: Panayiatopolis CP, Crawford PM, Thomson T, editors. Educational kit on epilepsies, vol 4, epilepsy and women. Oxford: Medicinae; 2008. p. 96\u2013104."},{"key":"288_CR33","unstructured":"Faculty of Sexual and Reproductive Healthcare Clinical Effectiveness Unit. Clinical guidance: drug interactions with hormonal contraception. 2011. Available at: http:\/\/www.fsrh.org\/pdfs\/CEUGuidanceDrugInteractionsHormonal.pdf Accessed December 21, 2013. Hormonal contraceptive guidelines detailing potential interactions with anti-epileptic drugs."},{"key":"288_CR34","volume-title":"Women and epilepsy","author":"T Betts","year":"1998","unstructured":"Betts T, Crawford P. Women and epilepsy. London: Martin Dunitz; 1998."},{"issue":"9","key":"288_CR35","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1111\/j.1528-1167.2006.00671.x","volume":"47","author":"M O\u2019Brien","year":"2006","unstructured":"O\u2019Brien M, Guillebaud J. Contraception for women with epilepsy. Epilepsia. 2006;47(9):1419\u201322.","journal-title":"Epilepsia"},{"key":"288_CR36","unstructured":"Pharmacia Limited. Depo-Provera 150\u00a0mg\/mL injection: Summary of Product Characteristics (SPC). 2007. Available at: http:\/\/www.medicines.org.uk\/emc Accessed December 22, 2013."},{"key":"288_CR37","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1210\/jc.2007-2201","volume":"93","author":"JS Walsh","year":"2008","unstructured":"Walsh JS, Eastell R, Peel NF. Effects of depot medroxyprogesterone acetate on bone density and bone metabolism before and after peak bone mass: a case-control study. J Clin Endocrinol Metab. 2008;93:1317\u201323.","journal-title":"J Clin Endocrinol Metab"},{"key":"288_CR38","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/0010-7824(86)90044-2","volume":"33","author":"M Haukkamaa","year":"1986","unstructured":"Haukkamaa M. Contraception by Norplant subdermal capsules is not reliable in epileptic patients on anticonvulsant therapy. Contraception. 1986;33:559\u201365.","journal-title":"Contraception"},{"key":"288_CR39","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00404-005-0064-4","volume":"273","author":"C Schindlbeck","year":"2006","unstructured":"Schindlbeck C, Janni W, Friese K. Failure of Implanon contraception in a patient taking carbamazepine for epilepsy. Arch Gynecol Obstet. 2006;273:255\u20136.","journal-title":"Arch Gynecol Obstet"},{"key":"288_CR40","unstructured":"HRA Pharma UK Ltd. ellaOne: Summary of Product Characteristics. 2010. Available at: http:\/\/www.medicines.org\/emc Accessed December 21, 2013."},{"key":"288_CR41","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1783\/147118902101195992","volume":"28","author":"W Bounds","year":"2002","unstructured":"Bounds W, Guillebaud J. Observational series on women using the contraceptive Mirena concurrently with anti-epileptic and other enzyme-inducing drugs. J Fam Plan Reprod Health Care. 2002;28:78\u201380.","journal-title":"J Fam Plan Reprod Health Care"}],"container-title":["Current Treatment Options in Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-014-0288-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11940-014-0288-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-014-0288-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T13:47:34Z","timestamp":1716644854000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11940-014-0288-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,1]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["288"],"URL":"https:\/\/doi.org\/10.1007\/s11940-014-0288-3","relation":{},"ISSN":["1092-8480","1534-3138"],"issn-type":[{"value":"1092-8480","type":"print"},{"value":"1534-3138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,1]]},"article-number":"288"}}